itching all over; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory authority (ra). the reporter is the patient. a 60 year-old female patient received bnt162b2 (bnt162b2), administration date 20apr2021 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. patient has not had symptoms associated with covid-19. patient was not enrolled in clinical trial. past drug history included: simvastatin, notes: dose: 20 mg. vaccination history included: bnt162b2 (dose 1, lot-ek4244), administration date: 04feb2021, for covid-19 immunisation. the following information was reported: pruritus (medically significant) with onset 15may2021, outcome "unknown", described as "itching all over". itching all over has got much worse since i had the moderna on the 26nov2021 batch number 3004737. the patient underwent the following laboratory tests and procedures: blood test: (unspecified date) negative, notes: nothing showing up; laboratory test: (unspecified date) negative, notes: nothing showing up; sars-cov-2 test: (16feb2022) negative, notes: no - negative covid-19 test. patient has not tested positive for covid-19 since having the vaccine. the report was considered not relate to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200291419 same patient/drug and different dose events

test name: blood test; test result: negative ; comments: nothing showing up; test name: private tests done; test result: negative ; comments: nothing showing up; test date: 20220216; test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test

na

na